Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Oncogene
|
July 3, 1999
p53-Dependent growth arrest and altered p53-immunoreactivity following metabolic labelling with 32P ortho-phosphate in human fibroblasts
J A Bond, K Webley, F S Wyllie, et al.
British Journal of Cancer
|
February 1, 1988
Ha-ras restriction fragment length polymorphisms in colorectal cancer
F S Wyllie, V Wynford-Thomas, N R Lemoine, et al.
Oncogene
|
February 1, 1989
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis
N R Lemoine, E S Mayall, F S Wyllie, et al.
Cancer Research
|
June 1, 1995
Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1
J A Bond, J P Blaydes, J Rowson, et al.
British Journal of Cancer
|
October 1, 1989
Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation
P A Wright, N R Lemoine, E S Mayall, et al.
Molecular and Cellular Biology
|
March 19, 1999
Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis
J A Bond, M F Haughton, J M Rowson, et al.
Molecular and Cellular Biology
|
October 1, 1990
Conditional immortalization of human thyroid epithelial cells: a tool for analysis of oncogene action
D Wynford-Thomas, J A Bond, F S Wyllie, et al.
Nature Genetics
|
December 30, 1999
Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts
F S Wyllie, C J Jones, J W Skinner, et al.
Experimental Cell Research
|
May 23, 1998
Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells
C J Jones, A Soley, J W Skinner, et al.
Oncogene
|
September 1, 1991
Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours
P A Wright, N R Lemoine, P E Goretzki, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Oncogene
|
July 3, 1999
p53-Dependent growth arrest and altered p53-immunoreactivity following metabolic labelling with 32P ortho-phosphate in human fibroblasts
J A Bond, K Webley, F S Wyllie, et al.
British Journal of Cancer
|
February 1, 1988
Ha-ras restriction fragment length polymorphisms in colorectal cancer
F S Wyllie, V Wynford-Thomas, N R Lemoine, et al.
Oncogene
|
February 1, 1989
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis
N R Lemoine, E S Mayall, F S Wyllie, et al.
Cancer Research
|
June 1, 1995
Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1
J A Bond, J P Blaydes, J Rowson, et al.
British Journal of Cancer
|
October 1, 1989
Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation
P A Wright, N R Lemoine, E S Mayall, et al.
Molecular and Cellular Biology
|
March 19, 1999
Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis
J A Bond, M F Haughton, J M Rowson, et al.
Molecular and Cellular Biology
|
October 1, 1990
Conditional immortalization of human thyroid epithelial cells: a tool for analysis of oncogene action
D Wynford-Thomas, J A Bond, F S Wyllie, et al.
Nature Genetics
|
December 30, 1999
Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts
F S Wyllie, C J Jones, J W Skinner, et al.
Experimental Cell Research
|
May 23, 1998
Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells
C J Jones, A Soley, J W Skinner, et al.
Oncogene
|
September 1, 1991
Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours
P A Wright, N R Lemoine, P E Goretzki, et al.
Page
of 4